ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Saturday, 21 November 2026 Every NSE & BSE earnings call, live and summarised
ALFA Concalls Every earnings call, live and summarised

Earnings calls

Shree Ganesh Remedies concalls

Every Shree Ganesh Remedies earnings call we streamed: the live audio and our summary of what management said.

Calls

Sat, 14 Nov

Shree Ganesh Remedies

SGRLQ2 FY27 earnings call

Q2 revenue ₹23.29 Cr, up 62% QoQ but down 23% YoY; EBITDA margin fell to 17% from 32%. Management's 'stronger performance ahead' has no numbers, and it admits the recovery is incomplete.

Summary ready

Q2 FY27: key takeaways

Call page →

Q2 revenue ₹23.29 Cr, up 62% QoQ but down 23% YoY; EBITDA margin fell to 17% from 32%. Management's 'stronger performance ahead' has no numbers, and it admits the recovery is incomplete.

Outlook

No revenue or margin guidance given. Commercial supply from Q1 FY28; ~80% plant utilisation at peak, in three years.

Earlier call summaries

All →

Shree Ganesh Remedies Ltd: key numbers

Share price
₹605.80
Market cap
₹777.7 Cr
Revenue (annual)
₹109.3 Cr
Net profit (annual)
₹17.76 Cr
P/E (TTM)
64.2×Sector 49.0×
Promoter holding
72.84%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.